ReviewPLoS medicine2012
Researching new methods of screening for adverse pregnancy outcome: lessons from pre-eclampsia.
Review in PLoS medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.Health technology assessment (Winchester, England) · 2021Pooled it
- A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED).BMC pregnancy and childbirth · 2013Trial
- Article
- The human placenta and its role in reproductive outcomes revisited.Physiological reviews · 2025Review
- Slowing of fetal growth and elevated maternal serum sFLT1:PlGF are associated with early term spontaneous labor.American journal of obstetrics and gynecology · 2021Article
- Do Mass Spectrometry-Derived Metabolomics Improve the Prediction of Pregnancy-Related Disorders? Findings from a UK Birth Cohort with Independent Validation.Metabolites · 2021Article
- Folate metabolizing gene polymorphisms and genetic vulnerability to preterm birth in Korean women.Genes & genomics · 2021Article
- A maternal serum metabolite ratio predicts fetal growth restriction at term.Nature medicine · 2020Article
- Antenatal placental assessment in the prediction of adverse pregnancy outcome after reduced fetal movement.PloS one · 2018Article
- Gestational diabetes mellitus-right person, right treatment, right time?BMC medicine · 2017Article
- Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.Hypertension (Dallas, Tex. : 1979) · 2017Article
- Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction.Nature genetics · 2016Article
- First trimester screening for pre-eclampsia.Obstetric medicine · 2016Review
- Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study.Lancet (London, England) · 2015Article
- Placental Features of Late-Onset Adverse Pregnancy Outcome.PloS one · 2015Article
- Pre-eclampsia part 2: prediction, prevention and management.Nature reviews. Nephrology · 2014Review
- Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.American journal of obstetrics and gynecology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.